Back to Journals » Infection and Drug Resistance » Volume 14

Recent Advances in the Treatment of C. difficile Using Biotherapeutic Agents [Corrigendum]

Authors Giau VV , Lee H, An SSA , Hulme J

Received 30 October 2020

Accepted for publication 30 October 2020

Published 13 January 2021 Volume 2021:14 Pages 97—98

DOI https://doi.org/10.2147/IDR.S289562



Giau VV, Lee H, An SSA, Hulme J. Infect Drug Resist.  2019;12:1597– 1615.


Page 1599, Figure 1, the following copyright notice should have been included in the figure caption.


Adapted by permission from Springer Nature, Nature Reviews Disease Primers, Clostridium difficile infection, Smits W, Lyras D, Lacy D, et al, Copyright © 2016 (https://wtw.nature.com/nrdp). 189

Page 1615, References, the following reference should have been included in the reference list.

 

189. Smits W, Lyras D, Lacy D, et al. Clostridium difficile infection. Nat Rev Dis Primers. 2016;2:16020. https://doi.org/10.1038/nrdp.2016.20


The authors apologize for these errors.

Read the original article

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.